NDC 63304-211 Glycopyrrolate
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 63304 - Ranbaxy Pharmaceuticals Inc.
- 63304-211 - Glycopyrrolate
Product Characteristics
10 MM
RE29
Product Packages
NDC Code 63304-211-01
Package Description: 100 TABLET in 1 BOTTLE
NDC Code 63304-211-10
Package Description: 1000 TABLET in 1 BOTTLE
NDC Code 63304-211-30
Package Description: 30 TABLET in 1 BOTTLE
NDC Code 63304-211-69
Package Description: 1 BLISTER PACK in 1 BOX / 10 TABLET in 1 BLISTER PACK (63304-211-11)
Product Details
What is NDC 63304-211?
What are the uses for Glycopyrrolate?
Which are Glycopyrrolate UNII Codes?
The UNII codes for the active ingredients in this product are:
- GLYCOPYRROLATE (UNII: V92SO9WP2I)
- GLYCOPYRRONIUM (UNII: A14FB57V1D) (Active Moiety)
Which are Glycopyrrolate Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POVIDONE (UNII: FZ989GH94E)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
What is the NDC to RxNorm Crosswalk for Glycopyrrolate?
- RxCUI: 197738 - glycopyrrolate 1 MG Oral Tablet
- RxCUI: 197739 - glycopyrrolate 2 MG Oral Tablet
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".